Aligos Therapeutics, Inc. (ALGS) Net margin 2023–2025
Aligos Therapeutics, Inc. (ALGS) net profit margin by fiscal year — reported net income divided by reported revenue.
-1106.7%FY2025 · since FY2023: -1416.2% → -1106.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1106.7% | +2526.9 pp |
| FY2024 | -3633.6% | -2217.4 pp |
| FY2023 | -1416.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice